CN107110862B - 结核分枝杆菌蛋白 - Google Patents

结核分枝杆菌蛋白 Download PDF

Info

Publication number
CN107110862B
CN107110862B CN201580056106.6A CN201580056106A CN107110862B CN 107110862 B CN107110862 B CN 107110862B CN 201580056106 A CN201580056106 A CN 201580056106A CN 107110862 B CN107110862 B CN 107110862B
Authority
CN
China
Prior art keywords
fragments
pool
seq
mycobacterium tuberculosis
mycobacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580056106.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN107110862A (zh
Inventor
马西莫·阿米科桑特
伊恩·达兰特
斯科特·塔斯克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Immunotec Ltd
Original Assignee
Oxford Immunotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Immunotec Ltd filed Critical Oxford Immunotec Ltd
Publication of CN107110862A publication Critical patent/CN107110862A/zh
Application granted granted Critical
Publication of CN107110862B publication Critical patent/CN107110862B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
CN201580056106.6A 2014-08-15 2015-08-14 结核分枝杆菌蛋白 Active CN107110862B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
BG11180414 2014-08-15
BG111804 2014-08-15
BG11204515 2015-06-30
BG112045 2015-06-30
PCT/GB2015/052362 WO2016024129A1 (en) 2014-08-15 2015-08-14 Mycobacterium tuberculosis proteins

Publications (2)

Publication Number Publication Date
CN107110862A CN107110862A (zh) 2017-08-29
CN107110862B true CN107110862B (zh) 2021-03-16

Family

ID=53969374

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580056106.6A Active CN107110862B (zh) 2014-08-15 2015-08-14 结核分枝杆菌蛋白

Country Status (6)

Country Link
US (1) US10295538B2 (enExample)
EP (1) EP3180353B1 (enExample)
JP (2) JP6781698B2 (enExample)
CN (1) CN107110862B (enExample)
ES (1) ES2897933T3 (enExample)
WO (1) WO2016024129A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106442983B (zh) * 2016-08-31 2018-07-03 中国疾病预防控制中心传染病预防控制所 结核分枝杆菌抗原蛋白Rv3793及其T细胞表位肽的应用
CN106248936B (zh) * 2016-08-31 2018-09-25 中国疾病预防控制中心传染病预防控制所 结核分枝杆菌抗原蛋白Rv2201及其T细胞表位肽的应用
CN112020555B (zh) * 2018-05-02 2024-06-21 国立大学法人新潟大学 肽及其应用
CN116348767A (zh) 2020-10-06 2023-06-27 西菲伊德公司 诊断结核病以及区分活动性和潜伏性结核病的方法
GB202101078D0 (en) * 2021-01-27 2021-03-10 Oxford Immunotec Ltd Fragment pools
CN114736276B (zh) * 2022-05-24 2023-08-01 中国人民解放军总医院第八医学中心 结核分枝杆菌ltbi-rd相关蛋白抗原的ctl表位肽及其应用
CN115957312A (zh) * 2023-01-17 2023-04-14 武汉大学 B4galt1在制备抗结核分枝杆菌感染的药物中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103884847A (zh) * 2014-03-14 2014-06-25 中国科学院生物物理研究所 一种结核分枝杆菌全蛋白质芯片及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002314358C1 (en) * 2001-07-04 2009-03-26 The Secretary Of State For Health Mycobacterial antigens expressed during latency
WO2004099771A1 (en) * 2003-05-08 2004-11-18 Statens Serum Institut A new specific epitope based immunological diagnosis of tuberculosis
ITRM20040091A1 (it) * 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
GB0406271D0 (en) 2004-03-19 2004-04-21 Isis Innovation Diagnostic test
WO2006000045A1 (en) * 2004-06-25 2006-01-05 Proteome Systems Intellectual Property Pty Ltd Novel methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor i
WO2007131293A1 (en) * 2006-05-16 2007-11-22 Proteome Systems Limited Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor vi
US7776341B2 (en) 2006-08-10 2010-08-17 Colorado State University Research Foundation Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens
SI2315834T1 (sl) * 2008-07-25 2018-09-28 Glaxosmithkline Biologicals S.A. Tuberkulozni Rv2386c protein, sestavki in njegove uporabe
WO2010132054A1 (en) * 2009-05-13 2010-11-18 Immport Therapeutics, Inc. Compositions and methods for immunodominant antigens of mycobacterium tuberculosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103884847A (zh) * 2014-03-14 2014-06-25 中国科学院生物物理研究所 一种结核分枝杆菌全蛋白质芯片及应用

Also Published As

Publication number Publication date
JP2020198886A (ja) 2020-12-17
EP3180353B1 (en) 2021-09-22
WO2016024129A1 (en) 2016-02-18
JP2017526742A (ja) 2017-09-14
US10295538B2 (en) 2019-05-21
JP6781698B2 (ja) 2020-11-04
US20170234871A1 (en) 2017-08-17
CN107110862A (zh) 2017-08-29
ES2897933T3 (es) 2022-03-03
EP3180353A1 (en) 2017-06-21

Similar Documents

Publication Publication Date Title
CN107110862B (zh) 结核分枝杆菌蛋白
DK2417456T3 (en) DIAGNOSTIC TEST Mycobacterium tuberculosis
JP5221337B2 (ja) ミコバクテリア感染及び結核疾病の診断、予防及び治療のための方法及び手段
CN107102137A (zh) 用于检测结核分枝杆菌感染的抗原刺激物、试剂盒及其应用
CN103402533A (zh) 来自结核分枝杆菌的氨基酸序列或其相应核酸在诊断和预防结核感染、诊断试剂盒及其疫苗中的应用
JP3840596B2 (ja) ミコバクテリア感染のための治療の効力を決定するためのアッセイ法
CA2490172C (en) Diagnosis of recent tuberculosis infection by comparing t-cell antigenicity of esat-6 with epitopes thereof
US8865422B2 (en) Method for the diagnosis of tuberculosis
Stenger et al. Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells
Nagai et al. Immunological Responses and Epitope Mapping by Tuberculosis‐Associated Antigens within the RD1 Region in Japanese Patients
EP2696891A1 (en) New vaccines for prevention and treatment of tuberculosis
CN114671928B (zh) 一种结核分枝杆菌T细胞表位蛋白Rv1566c-444的应用
CN110475568B (zh) 多发性硬化症相关的自身抗原及其在疗法和诊断中的用途
Specht et al. BCG vaccination of Diversity Outbred mice induces cross-reactive antibodies to SARS-CoV-2 spike protein
CN106442983B (zh) 结核分枝杆菌抗原蛋白Rv3793及其T细胞表位肽的应用
JP2011102299A5 (enExample)
US20220187279A1 (en) Rapid t-cell assay for sars-cov-2
Okaa et al. Endoglucanase-2 (Eng2), a conserved immunodominant antigen in dimorphic fungi that elicits immunity and resistance during infection
WO2007091881A2 (en) Methods and means for detection of mycobacterium leprae infections

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant